New Zealand markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
26.26+0.26 (+1.00%)
At close: 04:00PM EDT
26.29 +0.03 (+0.11%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
2,119,000
2,119,000
31,372,000
21,979,000
9,159,000
Depreciation & amortisation
6,290,000
6,290,000
5,064,000
5,191,000
4,777,000
Deferred income taxes
-3,442,000
-3,442,000
-3,764,000
-4,293,000
-1,468,000
Stock-based compensation
525,000
525,000
872,000
1,182,000
756,000
Change in working capital
-2,172,000
-2,172,000
-5,639,000
12,804,000
-275,000
Accounts receivable
347,000
347,000
261,000
-3,811,000
-1,249,000
Inventory
-1,169,000
-1,169,000
-591,000
-1,125,000
-736,000
Accounts payable
-300,000
-300,000
1,191,000
1,242,000
353,000
Other working capital
4,793,000
4,793,000
26,031,000
29,869,000
12,177,000
Other non-cash items
-4,280,000
-4,280,000
-400,000
-4,696,000
-2,268,000
Net cash provided by operating activities
8,700,000
8,700,000
29,267,000
32,580,000
14,403,000
Cash flows from investing activities
Investments in property, plant and equipment
-3,907,000
-3,907,000
-3,236,000
-2,711,000
-2,226,000
Acquisitions, net
-43,430,000
-43,430,000
-22,997,000
0
0
Purchases of investments
-31,178,000
-31,178,000
-38,780,000
-47,613,000
-14,402,000
Sales/maturities of investments
46,417,000
46,417,000
45,462,000
28,096,000
12,730,000
Other investing activities
-180,000
-180,000
-192,000
-306,000
-264,000
Net cash used for investing activities
-32,278,000
-32,278,000
-15,783,000
-22,546,000
-4,271,000
Cash flows from financing activities
Debt repayment
-2,572,000
-2,572,000
-7,407,000
-2,100,000
-30,329,000
Common stock repurchased
0
0
-2,000,000
0
0
Dividends paid
-9,247,000
-9,247,000
-8,983,000
-8,729,000
-8,440,000
Other financing activities
-632,000
-632,000
-335,000
16,000
-445,000
Net cash used provided by (used for) financing activities
26,067,000
26,067,000
-14,834,000
-9,816,000
-21,639,000
Net change in cash
2,448,000
2,448,000
-1,515,000
159,000
475,000
Cash at beginning of period
468,000
468,000
1,983,000
1,825,000
1,350,000
Cash at end of period
2,917,000
2,917,000
468,000
1,983,000
1,825,000
Free cash flow
Operating cash flow
8,700,000
8,700,000
29,267,000
32,580,000
14,403,000
Capital expenditure
-3,907,000
-3,907,000
-3,236,000
-2,711,000
-2,226,000
Free cash flow
4,793,000
4,793,000
26,031,000
29,869,000
12,177,000